NIH #5R01CA262899-04
Multi-ethnic high-throughput study to identify novel non-HLA genetic contributors to mortality after blood and marrow transplantation
- Amount
- $594K
- Period
- 2021-08-01 → 2026-07-31
- PIs
- 3
- Est. capacity / PI
- ~0 students
Awarded at ROSWELL PARK CANCER INSTITUTE CORP